Company intelligence / Profile preview

EmSense

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

EmSense was a pioneering biometrics and neuromarketing company that developed non-invasive technology to measure physiological and cognitive responses to media and advertisements. The company's flagship product, the EmBand, was a lightweight EEG headset that captured brainwaves, heart rate, and skin conductance to provide real-time consumer insights. By integrating medical-grade sensors with proprietary analytics, EmSense aimed to quantify emotional engagement and cognitive load for market research. Despite significant venture backing and partnerships with major consumer brands, the company ceased operations in 2011.

Modalities: Device
Industry: Non-Drug Biotech

Partnerships

The Nielsen CompanyMicrosoftCoca-Cola

Beyond the preview

Go deeper on EmSense.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EmSense.

Explore the full profile